Blog

DEEP RESEARCH · ENCHEM

Enchem (348370.KQ): Conditions for an Electrolyte Turnaround After the Chasm

A review of 3Q25 volume-price decoupling, the North American FEOC moat, low utilization, and liquidity risk.

Published: 2025-11-30 · Battery-materials turnaround analysis · Naver Blog source

Investment decisions are your responsibility. This material is research and is not a recommendation to buy or sell.

0. Bottom line first

The source's conclusion is that Enchem is passing the peak of its CAPEX supercycle and may see operating leverage from utilization recovery beginning in 2026. But Chinese subsidiary losses, low cash liquidity, and utilization of roughly 10% remain key risks.

Official fact: Global EV shipments in 1Q-3Q 2025 rose about 30% YoY to 15.67 million units, while Europe rebounded with 32% growth in 2025. Enchem's 3Q25 electrolyte sales volume was 19,022 tons, up from 12,227 tons a year earlier and 11,476 tons in the prior quarter.

Interpretation: The source's volume-price decoupling comes from electrolyte pass-through pricing. LiPF6 moved from about RMB 63/kg in early 2025 to the RMB 50/kg range in the first half, then rebounded to about RMB 83.3/kg in November, but ASPs reflect raw-material moves with a 1-3 month lag.

Enchem turnaround pathBoth volume recovery and price normalization are needed
End demand15.67M EVs, Europe +32%
PricingLiPF6 rebound and ASP lag
North AmericaFEOC and non-China supply chain
IntegrationEDL, LiPF6, NMP
The U.S. subsidiary turning profitable is the most important proof point for group-level recovery.

1. Industry backdrop and FEOC moat

Electrolyte is local-production-sensitive because of shelf-life and deterioration issues. The source argues that with Chinese electrolyte makers constrained by FEOC rules, Enchem's Georgia and Tennessee plants can become rare large-scale non-China supply capacity in North America.

2. Customers and supply chain

Customer/axisSource contentMeaning
LG Energy SolutionCore partner for North American GM JV, Honda JV, and PolandEnchem volume is tied to North American ramp-up
SK OnGeorgia, Hungary, and BlueOval SK exposureYield stabilization and utilization recovery are key variables
Tesla/PanasonicCited as potential growth customersA 4680 direct-supply contract could support re-rating
EDLSaemangeum LiPF6 internalization JVReduces dependence on lithium salt, about 40% of electrolyte cost

3. Turnaround scorecard

ItemSource statusBasis
IndustryPositiveEV demand recovery and non-China supply-chain demand from IRA/CRMA
Operating efficiencyNeutralAbout 10% utilization is painful now but creates operating leverage later
Financial healthCautionKRW 12.0 billion cash-like assets and rising short-term borrowings
ProfitabilityImprovingU.S. subsidiary profitability, expected inventory-cost improvement, positive OCF
Competitive edgeExcellentEarly North America/Europe capacity plus NMP and lithium-salt integration

4. Scenarios

Bull Case

  • North America Plant 2 starts in early 2026 and LGES/SK On JV volumes lift utilization above 40%.
  • AMPC benefits are clearly applied to electrolyte or reflected favorably in pricing.
  • A Tesla 4680 direct supply contract expands the valuation multiple.

Bear Case

  • The EV chasm persists and customer utilization recovery is delayed.
  • Cash depletion leads to a large rights offering and share dilution.
  • Chinese workarounds or tariff relief weaken the North American position.

5. My conclusion

Enchem fits the source's description of a turnaround candidate with growing pains. I would track U.S. subsidiary profit growth, operating cash flow, financing terms, and the pace of LiPF6 internalization more than the headline loss alone.

Sources

Naver original